CCAAT/enhancer binding protein-a (C/EBPa) induces transdifferentiation of B cells into macrophages at high efficiencies and enhances reprogramming into induced pluripotent stem (iPS) cells when co-expressed with the transcription factors Oct4 (Pou5f1), Sox2, Klf4 and Myc (hereafter called OSKM) 1, 2 . However, how C/EBPa accomplishes these effects is unclear. Here we find that in mouse primary B cells transient C/EBPa expression followed by OSKM activation induces a 100-fold increase in iPS cell reprogramming efficiency, involving 95% of the population. During this conversion, pluripotency and epithelial-mesenchymal transition genes become markedly upregulated, and 60% of the cells express Oct4 within 2 days. C/EBPa acts as a 'path-breaker' as it transiently makes the chromatin of pluripotency genes more accessible to DNase I. C/EBPa also induces the expression of the dioxygenase Tet2 and promotes its translocation to the nucleus where it binds to regulatory regions of pluripotency genes that become demethylated after OSKM induction. In line with these findings, overexpression of Tet2 enhances OSKMinduced B-cell reprogramming. Because the enzyme is also required for efficient C/EBPa-induced immune cell conversion 3 , our data indicate that Tet2 provides a mechanistic link between iPS cell reprogramming and B-cell transdifferentiation. The rapid iPS reprogramming approach described here should help to fully elucidate the process and has potential clinical applications.
CCAAT/enhancer binding protein-a (C/EBPa) induces transdifferentiation of B cells into macrophages at high efficiencies and enhances reprogramming into induced pluripotent stem (iPS) cells when co-expressed with the transcription factors Oct4 (Pou5f1), Sox2, Klf4 and Myc (hereafter called OSKM) 1, 2 . However, how C/EBPa accomplishes these effects is unclear. Here we find that in mouse primary B cells transient C/EBPa expression followed by OSKM activation induces a 100-fold increase in iPS cell reprogramming efficiency, involving 95% of the population. During this conversion, pluripotency and epithelial-mesenchymal transition genes become markedly upregulated, and 60% of the cells express Oct4 within 2 days. C/EBPa acts as a 'path-breaker' as it transiently makes the chromatin of pluripotency genes more accessible to DNase I. C/EBPa also induces the expression of the dioxygenase Tet2 and promotes its translocation to the nucleus where it binds to regulatory regions of pluripotency genes that become demethylated after OSKM induction. In line with these findings, overexpression of Tet2 enhances OSKMinduced B-cell reprogramming. Because the enzyme is also required for efficient C/EBPa-induced immune cell conversion 3 , our data indicate that Tet2 provides a mechanistic link between iPS cell reprogramming and B-cell transdifferentiation. The rapid iPS reprogramming approach described here should help to fully elucidate the process and has potential clinical applications.
Reprogramming of somatic cells into induced pluripotent stem (iPS) cells by the OSKM transcription factors (also called Yamanaka factors) can be divided into a stochastic and a deterministic phase 4, 5 . During this process cells undergo a mesenchymal-epithelial transition (MET) and activate endogenous pluripotency genes, paralleled by changes in histone marks, nucleosome positioning and chromatin accessibility 6 . In addition, their promoters become de-methylated, preceded by oxidation of methylated CpGs through the dioxygenases Tet2 and Tet1, both of which have been implicated in the establishment of pluripotency 7, 8 . Earlier work showed that co-expression of C/EBPa with OSKM increases the reprogramming efficiency of B cells ,15-fold, reaching ,3% of the population 1 . Here we describe that a pulse of C/EBPa followed by OSKM overexpression permits the rapid reprogramming of B cells into iPS cells by activating Tet2 and facilitating accessibility of pluripotency gene promoters to Oct4 binding. Highly efficient reprogramming of somatic cells has recently also been reported with a loss-of-function approach 9 . Committed B-cell precursors (hereafter referred to as B cells) can be induced to transdifferentiate into macrophages at 100% efficiency by forced C/EBPa expression, deregulating ,7,500 genes 10 . Reasoning that chromatin of cells in transition might be more 'open' than that of end stages, we tested the effect of transiently exposing B cells to C/EBPa, followed by OSKM expression. B cells were isolated from the bone marrow of reprogrammable mice (containing a tetracycline-controlled transactivator (rtTA) and a doxycycline-responsive OSKM cassette 11 ), infected them with C/EBPa-ER-hCD4 retrovirus, sorted human CD4 1 cells 4 days later and incubated them for different times with b-estradiol (E2) followed by a wash-out (Fig. 1a) . Subsequently, OSKM was induced by doxycycline treatment and Nanog 1 colonies scored 12 days post induction (d.p.i.). B cells continuously co-expressing C/EBPa with OSKM showed an 11-fold enhancement in reprogramming efficiency compared to cells induced with OSKM alone (B1OSKM cells), confirming earlier reports 1, 12 . In contrast, cells treated for 18 h with E2 and then treated with doxycycline (Ba91OSKM cells) exhibited a 103-fold colony increase, with cells pulsed for 6 h already showing a 74-fold increase ( Fig. 1b-d) . Clonal assays showed that 92-94% of viable colonies were Nanog 1 after 12 days (Extended Data Fig. 1a-c ). OSKM induction of B cells pre-treated with E2 did not increase Nanog 1 colony numbers nor Oct4 expression levels (Extended Data Fig. 2a) . A mutant of C/EBPa (BRM-2 (ref. 13)) defective for DNA binding failed to enhance iPS cell generation (Extended Data Fig. 2b ). Induced Ba91OSKM cells remained .50% viable (Extended Data Fig. 2c ). C/EBPa pulses after OSKM induction had no effect on reprogramming efficiency (Extended Data Fig. 2d ), indicating that C/EBPa acts as a path-breaker for OSKMinduced reprogramming. Stable iPS cell lines derived from Ba91OSKM cells (aiPS cells) displayed similar gene expression profiles as embryonic stem (ES) cells, differentiated into all three germ layers in vitro and in vivo, and efficiently contributed to coat colour chimaerism ( Fig. 1e and Extended Data Fig. 3a-e) .
Ba91OSKM-derived iPS cell colonies could be identified as early as 4 d.p.i. and their numbers increased modestly after 8 days (Fig. 1f, g ), whereas B1OSKM colonies continued to increase 8-10 d.p.i. (Fig. 1f, g ). Retroviral hCD4 expression was found to be silenced within 2-4 days in Ba91OSKM cells compared to ,8 days in B1OSKM cells (Fig. 1h) . To test the effect of C/EBPa on OSKM-induced transgene independence, Ba9 and B cells were doxycycline-treated for different times (Fig. 1i) . The first transgene-independent iPS cell colonies were observed after 4 days for Ba91OSKM cells, compared to 9-10 days for B1OSKM controls (Fig. 1j ). Together these results show that the C/EBPa pulse accelerates iPS cell reprogramming by 4-6 days.
Gene expression analyses of Ba91OSKM cells 8 d.p.i. showed the upregulation of 764 out of 1,668 genes expressed more highly in ES cells than in B cells, including all well described pluripotency genes (Fig. 2a) . Unsupervised hierarchical clustering analysis revealed that 8 d.p.i. Ba1OSKM cells clustered with ES/iPS cells (Extended Data  Fig. 4a) . A large part of known pluripotency genes were activated 2-6 d.p.i. (Fig. 2b, c and Extended Data Fig. 4b ), reaching levels comparable to aiPS cells and ES cells within ,1 week ( Fig. 2c and Extended Data Fig. 4c ). In contrast, they remained essentially silent in B1OSKM cells (Fig. 2b, c ). In addition, five genes described to be activated very late (21 d (Fig. 2d, e) , with a similar viability as in serum containing medium. Induced B1OSKM cells died without serum.
We next scored the expression of MET genes 15, 16 . Ba91OSKM cells upregulated all epithelial genes tested and expressed E-cadherin 2-4 d.p.i., again with B1OSKM cells remaining negative (Extended Data Fig. 5a, b) . In line with the possibility that the C/EBPa pulse is capable of initiating an epithelial-mesenchymal transition (EMT) 17 , mesenchymal genes encoding TGF-b pathway members, transcription factors and collagens were first upregulated by the C/EBPa pulse and then switched off after OSKM induction (Extended Data Fig. 5a , e). To compare gene expression changes during OSKM-induced reprogramming of Ba9 cells with C/EBPa-induced transdifferentiation of B cells we selected genes selectively expressed in macrophages (263) and B cells (83) (Supplementary Table 1 ). Most of these genes were already up-or downregulated in Ba9 cells, respectively, as expected from the induced conversion (Extended Data Fig. 6a ). After OSKM induction, B-cell genes became further silenced whereas macrophage genes elicited a more heterogeneous response (Extended Data Fig. 6b, c) . Ba91OSKM cells at 2-4 d.p.i. co-expressed E-cadherin and the macrophage markers CSF-1R and Mac1, whereas B1OSKM cells remained negative and aiPS cells expressed exclusively E-cadherin (Extended Data Fig. 6d ). Sorted Mac1 Fig. 6e) . Analysis of the 18 h pulsed B cells by RNA-seq revealed 1,418 upregulated and 552 downregulated genes (Extended Data Fig. 7a ). Gene set enrichment analysis (GSEA) showed a strong correlation between genes downregulated in Ba9 cells with sets of B-cell-specific genes, and upregulated genes with genes related to EMT, collagen expression and the TGF-b pathway (Extended Data Fig. 7b ), confirming the array data. C/EBPa chromatin immunoprecipitation sequencing (ChIP-seq) analysis revealed 1,766 DNA regions bound by the protein in Ba9 cells of which ,20% were within 50 kb of genes whose expression changed (Extended Data Fig. 7c-g ). These included two regulatory sites in Tet2 (Fig. 3a, ref. 3) as well as sites close to lymphoid, MET and TGF-b pathway genes. Tet2 became upregulated ,1.6-fold after the 18-h pulse and was further activated by OSKM, reaching levels comparable to ES cells within 2 days (Fig. 3b, c) . In contrast, mouse embryonic fibroblasts (MEFs) pulsed with C/EBPa did not upregulate the gene (Extended Data Fig. 8a ). Tet2 overexpression enhanced iPS cell reprogramming of B cells ,3-fold (Fig. 3d) , supporting the reported role of Tet2 in iPS cell formation 7, 8 . Because the Tet2-induced 5-hydroxymethylcytosine (5hmC) modification has been described to participate in the maintenance of pluripotency, we determined 5hmC levels by hydroxymethylated DNA immunoprecipitation followed by qPCR (hMeDIP-qPCR) in Ba9 cells at regulatory regions of nine pluripotency genes for which hydroxymethylation levels change during reprogramming 18 . 5hmC levels were significantly increased for all genes tested ( 
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for active DNA demethylation, we analysed the DNA methylation status of the Oct4 and Nanog promoters using bisulphite sequencing (Fig. 3h) . Whereas the Oct4 promoter became partially demethylated in Ba91OSKM as early as 2 d.p.i. (Fig. 3h) , the Nanog promoter only became demethylated at 8 d.p.i., consistent with the observed delayed upregulation of the gene (Fig. 2b, c) .
The 5hmC changes at pluripotency genes raised the possibility that the C/EBPa pulse eliminates epigenetic barriers, increasing chromatin accessibility to the OSKM transcription factors. To test this, we performed quantitative DNase I sensitivity assays on selected regulatory regions of pluripotency genes. This revealed increased accessibility to the enzyme of all sites tested in the 18-h pulsed B cells whereas control regions and pluripotency sites in control B1OSKM cells showed no difference (Fig. 4a) . Interestingly, after prolonged induction of C/EBPa (72 h) the chromatin of pluripotency genes returned to the closed state as seen in untreated B cells (Extended Data Fig. 9a ). In addition, no demethylation of the Nanog and Oct4 promoters was observed (Extended Data Fig. 9b ). We next tested Oct4 occupancy in OSKMinduced Ba9 cells at sites within enhancers and promoters of pluripotency genes bound by Oct4 in ES cells 19 ( Fig. 4b) . At 2 d.p.i. all of these sites showed significant Oct4 occupancy, whereas they remained unbound in B1OSKM cells (Fig. 4b) . Together, these findings show that the C/EBPa pulse transiently induces chromatin remodelling at regulatory regions of pluripotency genes, making them rapidly accessible to Oct4 binding.
Our results show that C/EBPa poises B cells for highly efficient and almost immediate reprogramming into iPS cells by OSKM transcription factors, with MET and pluripotency network activation occurring concomitantly (summarized in Extended Data Fig. 9c ). In addition, our data indicate that the C/EBPa pulse already initiates an EMT, reminiscent of the recently described EMT-MET transition during reprogramming of fibroblasts 17 . The single cell cloning and Oct4-GFP reporter experiments suggest that essentially 100% of the poised cells can be reprogrammed into iPS cells. Several lines of evidence suggest that the rapid demethylation of the Oct4 promoter involves Tet2: the C/EBPa pulse directly binds to and upregulates the Tet2 gene and shuttles the protein into the nucleus. Then Tet2 binds to regulatory sites of Oct4 and other pluripotency genes, converting 5mC residues into 5hmC (summarized in Fig. 4c ). This modification might directly cause the gene's de-repression or be linked to demethylation and/or induction of chromatin remodelling 8 . The effect of C/EBPa is highly specific as only the closely related factor C/EBPb, but not the lineage-instructive factors GATA1 (ref. 20) , nor Mash1 or MyoD expressed in fibroblasts, was active (Extended Data Fig. 10a-i) . C/EBPa also sensitized T-cell precursors 21 but not fibroblasts (Extended Data Fig. 10j, k) . However, when C/EBPa was co-expressed with PU.1, a condition that mediates transdifferentiation to macrophage-like cells 22 , it induced a ,6-fold enhancement of iPS cell reprogramming, whereas PU.1 alone had no effect (Extended Data Fig. 10k ). This indicates that a myeloid determinant sensitizes somatic cells for iPS cell reprogramming, in line with 
the finding that macrophage/granulocyte progenitors, the formation of which is driven by C/EBPa 23 , show the highest described reprogramming efficiency of somatic cells (25%) 12 . The C/EBPa effect might recapitulate an embryonic function of the gene as it is required, in combination with C/EBPb, for the formation of functional trophoblasts 24 , cells with intriguing similarities to macrophages 25 .
METHODS SUMMARY
Somatic cells used for iPS cell reprogramming were derived from the reprogrammable mouse 11 . ES cells and iPS cells were cultured on mitomycin-C-treated MEFs in ES cell medium containing 15% FBS and 1,000 U ml 21 of LIF. For B-and T-cell reprogramming experiments the medium was supplemented with cell-type-specific cytokines 12 . OSKM expression was induced with 2 ng ml 21 of doxycycline. aiPS cells and iPS cells correspond to individual iPS cell clones obtained after expansion into stable lines of OSKM induced Ba9 and B cells, respectively. The total number of iPS cell colonies was scored after alkaline phosphatase or Nanog staining. For qRT-PCR and microarray analyses, B cells at different time points during reprogramming, as well as ES cells and iPS cells, were trypsinized and FACS sorted to remove feeder cells and dead cells. Total RNA was extracted using the miRNeasy kit (Qiagen). Microarrays were done using Agilent 8X60K expression arrays. Details on injections into blastocysts to test for chimaerism are provided in Methods.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Mice. The reprogrammable mouse containing a tetracyclin-inducible OSKM cassette as well as rtTA has been described previously 11 . Cell cultures. ES cells and iPS cells were cultured on mitomycin-C-treated MEF feeder cells in KO-DMEM (Invitrogen) supplemented with L-glutamine, penicillin/streptomycin, non-essential amino acids, b-mercaptoethanol, 1,000 U ml 21 LIF (ES cell medium) and 15% fetal bovine serum (FBS, Invitrogen).
MEF cultures were established by trypsin digestion of mouse embryos (embryonic day 13.5) and the resulting cells cultured in DMEM supplemented with 10% FBS, L-glutamine and penicillin/streptomycin. CD19
1 pro-B and pre-B cells were isolated from bone marrow using monoclonal antibodies to CD19 (1D3), obtained from BD Pharmingen, using MACS (Miltenyi Biotech). Double-negative (DN) T cells were prepared from thymii of 4-week-old mice by lineage depletion with Streptavidin microbeads. The following biotin-conjugated antibodies were used to label lineage (lin)-positive thymocytes before lineage depletion: CD3 (145-2C11), CD4 (GK1.5), CD8 (53-6.7), B220 (RA3-6B2), CD19 (1D3), Mac1/CD11b (M1/70), Gr1 (RB6-8C5), Ter119 (TER-119), I-A/I-E (2G9). The purity of the sorted cell fractions was confirmed by FACS using an LSR II machine (BD). After isolation, B cells were expanded in RPMI medium supplemented with 10% FBS and IL-7 for 1 week before inducing reprogramming. T cells were grown RPMI medium supplemented with 10% FBS supplemented with IL-7, Flt3 and SCF. Reprogramming. Reprogramming experiments were conducted in gelatinized plates seeded with a feeder layer of the OP9 stromal cell line, using ES cell medium supplemented with 2 mg ml 21 of doxycycline and 15% FBS. For the reprogramming of B cells, IL-4 (10 ng ml 21 ), IL-7 (10 ng ml
21
) and IL-15 (2 ng ml
) were added to the medium (ref. 13 ). B cells were seeded at a density of 500 cells cm 22 in 6-well plates. For the conditioning of Ba9 cells, C/EBPa-infected sorted B cells were exposed for 18 h to 100 nM of b-estradiol (E2) followed by inducer wash-out and addition of ES cell medium supplemented with doxycycline and cytokines. Serum-free iPS reprogramming was performed in serum-free ES cell medium (KO-DMEM supplemented with 15% knockout serum replacement, L-glutamine, penicillin/streptomycin, non-essential amino acids, b-ME, 1,000 U ml 21 LIF, N2 (100X), B27 (100X)) 9 supplemented with 2 mg ml 21 doxycycline to activate OSKM factors. 2i inhibitors were added to the medium 2 days after doxycycline induction.
For expansion of iPS cell lines, colonies with ES cell morphology were picked after doxycycline withdrawal at 12 d.p.i. OSKM MEFs were seeded on mitomycin-Ctreated MEF feeders in ES cell medium containing FBS and induced with doxycycline. Vectors and virus production and infection. C/EBPa-ER-GFP, C/EBPa-ER-CD4, C/EBPb, PU.1, C/EBPa-BRM-2 retroviruses and shPax5 lentivirus have been described previously 1, 2, 13 . Gata1 cDNA was cloned by PCR in the BglII/XhoI restriction sites of the MIG vector. The MyoD-ER plasmid was obtained from P. Muñoz, Mash1 from V. Broccoli. The retroviral vector for murine Tet2 overexpression was derived from MSCV-based pMIRWAY-puro-TET2 26 by replacing puro with EGFP. Virus production has been described previously 27 . Briefly, HEK293T cells were co-transfected with vector plasmid and packaging plasmids using calcium phosphate transfection. Viral supernatants were collected 48-72 h later and concentrated by ultracentrifugation at 20,000g for 2 h at 20 uC. Viral concentrates were re-suspended in 1 3 PBS and stored at 280 uC. Infection of MEFs was carried out in medium containing 5 mg ml 21 polybrene, and infection of B cells by centrifugation with concentrated virus for 2 h at 32 uC at 1000g in B-cell medium. Alkaline phosphatase staining. For alkaline phosphatase staining, the cells were fixed in 2% paraformaldehyde and then incubated for 15 min in NTMT solution (NaCl 100 mM, Tris A 1 M, Tris B 1 M, MgCl 2 50 mM, Tween 0.1%) supplemented with BCIP e NBT (Roche). Immunofluorescence assays. The cells were fixed with 4% paraformaldehyde, blocked and incubated with primary antibodies overnight at 4 uC. On the next day, the cells were exposed to secondary antibodies (all Alexa Fluor from Invitrogen) at room temperature for 1 h. The primary antibodies used were Nanog (Calbiochem), Oct4 (SC-5279), SMA (obtained from P. Muñoz), Tuj1 (obtained from V. Broccoli), Foxa2 (obtained from S. Aznar Benitah) and Tet2 (SC-61). Nuclear staining was performed with DAPI (Invitrogen). Differentiation of iPS cells. Embryoid bodies (EBs) were derived by plating iPS cells at a concentration of 1.3 3 10 6 cells ml 21 in non-adherent dishes in ES medium without LIF. After 4 days in suspension, cell aggregates were plated on gelatine-coated dishes in DMEM medium supplemented with 10% FBS for 10 days. Teratoma assay. One million iPS cells were injected subcutaneously into SCID BEIGE mice. Three weeks after the injection, the tumours were surgically removed and embedded in paraffin. Teratomas were sectioned into 10-mm-thick slices using a cryostat (Leica, CM1850 UV) and sections were stained with haematoxylin and eosin. Chimaeric mice. For the chimaera formation assay, 10-15 iPS cells (C57BL/6J background, black coat colour) were injected into a 3.5 days post coitum (d.p.c.) blastocyst of CD1 mice (white coat colour) and transferred into pseudo-pregnant 2.5 d.p.c. CD-1 recipients for chimaera generation. Chimaerism was ascertained after birth by the appearance of black coat colour (from the C57BL/6J iPS cells) over the white background from the host pups. FACS. Cell suspensions were stained with various antibodies from either BD Pharmingen or eBiosciences. Cells were analysed with an LSR II FACS (BD Biosciences) using Diva v6.1.2 (BD Biosciences) and FlowJo software v10.0.6 (TreeStar). Primary antibodies used were CD19, Mac1, B220, Cdh1, CD115 (all from BD Biosciences), hCD4 (eBioscience) and Nanog (Calbiochem). RNA isolation and quantification. RNA isolation of MEFs and B cells was done with the miRNeasy mini kit (Qiagen). RNA was collected from sorted live cells at 0, 2, 4, 6 and 8 d.p.i. To remove the feeders, ES cells and iPS cell clones at passage 2 or higher were seeded on gelatinized plates and processed with the above kits. RNA was eluted from the columns using RNase-free water or TE buffer and quantified by Nanodrop. cDNA was produced with the High Capacity RNA-to-cDNA kit (Applied Biosystem). Gene expression arrays and qRT-PCR. RNA samples (with an RNA integrity number (RIN) greater than 9) were subjected to transcriptional analyses using Agilent expression arrays. For hybridization, 500 ng of total RNAs were labelled using Agilent's QuickAmp labelling kit following manufacturer instructions and analysed using Agilent 8X60K expression arrays. For the expression data with multiple probes annotated to the same gene only the most dynamic probe as defined by all array hybridizations was considered. Genes with expression changes during reprogramming were defined as showing .4-fold differences between ES cells and uninduced B cells, and having a Student's t-test P value ,0.05 between technical duplicates. B-cell-and macrophage-specific genes were defined by combining array data from a previous study 28 . Lineage-specific genes were defined as .4-fold upregulated in one lineage over all of the others. Macrophage-specific genes were selected on the basis of .4-fold upregulation in primary macrophages and 5-day C/EBPa-induced macrophages as compared to B cells.
Unsupervised clustering was performed on Pearson correlation coefficients calculated between the indicated array samples using all genes that changed expression at least 2-fold between B cells and ES cells (n 5 10,982). Data were analysed and visualized using R v2.15.1.
The array data are available from the Gene Expression Omnibus under the accession number GSE52397.
qRT-PCR reactions were set up in triplicate with the SYBR Green QPCR Master Mix (Applied Biosystem) and primers as listed in Supplementary Table 2. Reactions were run on an AB7900HT PCR machine with 40 cycles of 30 s at 95 uC, 30 s at 58 uC and 30 s at 72 uC. Chromatin immunoprecipitation. ChIP experiments were performed as described previously 29 . Antibodies against Oct4 (SC-8626) and C/EBPa (SC-61) were purchased from Santa Cruz Biotechnologies. Tet2 ChIP was performed as in ref. 3 . Data were obtained from three biological replicates, three independent immunoprecipitations and three technical triplicates.
For ChIP-seq analysis, reads were mapped onto mouse mm9 genome using bowtie2 (v2.1.0) (parameter:-very-sensitive). Reads filtering was done using SAMtools to keep reads that map only once, with a quality score of 10 or more, and to remove duplicates. Peaks were called using HOMER (v4.3) (parameter: style factor) and peaks were selected to control the false discovery rate at 0.001. Peaks annotation and genes association (Extended Data Fig. 7b-d) was performed using HOMER and BedTools (v 2.17).
Circular plot (Extended Data Fig. 7e ) was done using Circos. The sequencing data are available under the Gene Expression Omnibus number GSE52397. DNA methylation. DNA was extracted using the Blood & Cell Culture DNA Mini kit (Qiagen). Bisulphite treatment of DNA was achieved using the EpiTect bisulphite kit (Qiagen) according to the manufacturer's instructions. The resulting modified DNA was amplified by polymerase chain reaction (PCR) using primer listed in Supplementary Table 2 . The resulting amplified products were gel-purified (Qiagen), subcloned into the pGEM-T Vector Systems (Promega), and sequenced using the T7 and SP6 primers. DNase I assay. Chromatin samples obtained as described before from two biological replicates were subjected to DNase I digestion. Briefly, 2 mg of chromatin were treated with 0.5, 1, and 2 units of DNase I (Roche) for 3 min at 37 uC in 13 DNase incubation buffer. Control samples were incubated in the absence of DNase I. Reactions were terminated by adding EDTA (40 mM final concentration) and the crosslinking was reversed by incubating the samples at 65 uC. After 6 h, proteinase K (40 mg ml 21 final concentration) was added to each reaction and incubated overnight at 37 uC. After careful phenol-chloroform extractions, the DNA was quantified and used as template for Real Time-PCR reactions using specific primers. hMeDIP. DNA extraction and IP (DIP) was carried out by a previously published protocol (http://www.epigenome-noe.net/, PROT33) with the following alterations.
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Genomic DNA was fragmented to a mean size of 350 bp using a Bioruptor (Diagenode) for 7330 s cycles. DNA (re-suspended in 13 IP buffer) was incubated with 5 mg of anti-OHMeC antibody (Active Motif) at 4 uC for 2 h, and 40 ml of a 1:1 mixture of BSA-blocked Protein A (Millipore 16-125) and Protein G (Millipore 16-266) agarose beads were added, followed by an additional 2 h incubation at 4 uC. After washing 3 times in 13 IP buffer, immune complexes were released by incubation with 70 mg Proteinase K, and DNA was extracted once with phenol, extracted once with chloroform, and recovered by EtOH precipitation for qPCR analysis. The 5hmC enrichment in the samples was assessed by qPCR and the values were normalized against Gapdh promoter. RNA-seq. RNA-seq was performed as described previously 30 . For RNA-seq analysis, reads were aligned onto mouse mm9 genome using STAR and Refseq mm9 annotation for splicing. Reads were filtered to keep only uniquely mapped reads with a maximum of two mismatches. Gene read count was performed using HTseq-count (parameter: mode 5 union, stranded, features 5 exons, attribute 5 gene_id) with Refseq mm9 annotation, and data were normalized using Bioconductor DEseq library (parameter: method 5 blind, sharingMode 5 fit-only, fitType 5 local). Genes with a read count above 300 in all conditions (set as a minimal threshold for functional expression) and genes with a 1.5-fold difference in normalized reads count between B cells and Ba9 cells were considered as differentially expressed. The sequencing data are available under the Gene Expression Omnibus number GSE52397. Statistical analysis and replicates. All data presented are representative of at least three independent experiments that yielded similar results. Statistical analyses were performed using Prism software (GraphPad).
